The enzyme 3&hyclroxysteroid dehydrogenaselA5-A4 isomerase (3@-HSD) catalyzes biosynthesis of progesterone (P) and all precursors of glucocorticoids, mineralocorticoids, androgens, and estrogens. Despite the broad interest raised by neurosteroids, the cellular localization of 3@-HSD has never been investigated in the brain. We took advantage of the availability of an antiserum raised against human placental 3@-HSD to determine the distribution of 3B-HSD-immunoreactive structures in the brain of the frog Rana ridibunda by the indirect immunofluorescence technique.
Three populations of 3/3-HSD-immunoreactive cell bodies were observed in the hypothalamus, namely, in the rostra1 region of the preoptic nucleus, the dorsal infundibular nucleus, and the dorsal part of the ventral infundibular nucleus. A dense network of 3&HSD-immunoreactive nerve fibers was visualized in the dorsal area of the diencephalon, that is, in the lateral neuropil, the corpus geniculatus lateralis, and the nucleus posterolateralis thalami.
Reversed-phase HPLC analysis of frog hypothalamic extracts combined with RIA detection showed the presence of substantial amounts of immunoreactive steroids coeluting with P and 17-hydroxyprogesterone (170H-P). The synthesis of A4-3-keto-steroids in the frog hypothalamus was investigated using the pulsechase technique with 3H-pregnenolone (3H-A5P) as a precursor. The formation of five tritiated metabolites of 3H-A5P was observed, one of which coeluted with 170H-P. Conversion of 3H-A5P into this radioactive metabolite was significantly reduced by trilostane, a specific inhibitor of BB-HSD. lmmunodetection of newly synthesized steroids in HPLC fractions of hypothalamic extracts, using 170H-P antibodies, revealed the existence of an immunoreactive steroid that exhibited the same retention time as synthetic 170H-P. The present study provides the first immunocytochemical mapping of 3&HSD, a key enzyme of the steroid biosynthetic pathway, in the CNS of a vertebrate.
The data also demonstrate for the first time biosynthesis of neurosteroids in the brain of a nonmammalian vertebrate. [Key words: 3B-hydroxysteroid dehydrogenase, 17-hydroxy-progesterone, neurosteroids, hypothalamic neurons, pulse chase, immunocytochemistry]
The enzyme 3/3-hydroxysteroid dehydrogenase/A5-A+'-isomerase (3/I-HSD) catalyzes the biosynthesis of A4-3-ketosteroids from As-3P-hydroxysteroids. This enzyme, which was originally identified in steroid hormone-producing organs such as adrenal, testis, ovary, and placenta, has also been found in other tissues including prostate, breast, liver, kidney, and skin (for review, see Labrie et al., 1992) . Different isoforms of 3&HSD, expressed in a cell-specific manner, have recently been characterized in mouse (Bain et al., 1991) , rat (Zhao et al., 1991) and human (Lachance et al., 1990, 199 1) .
One of the substrates of 3P-HSD is pregnenolone (ASP), which is generated from cholesterol by cytochrome P450,,,. Cytochrome P450,,, has been localized in the myelinated regions of the rat brain (Le Goascogne et al., 1987) and cultured rat glial cells have been shown to synthesize ASP (Jung-Testas et al., 1989) . Conversion of ASP to progesterone (P) has been reported in discrete regions of the CNS of the rat, suggesting that an active form of 3@-HSD is expressed in the brain (Weidenfield et al., 1980) . Biosynthesis of androstenedione (Al) from dehydroepiandrosterone (DHEA), another enzymatic reaction catalyzed by 3/3-HSD, has also been observed in the CNS of the rat (Robe1 et al., 1986) . However, although a 3@-HSD activity has been detected in primary cultures of rat oligodendrocytes (Jung-Testas et al., 1989) and mouse glial cells and neurons (Bauer and Bauer, 1989) , the cellular distribution of 3P-HSD in the CNS has never been determined. In addition, biosynthesis of steroid hormones has not been investigated before in the CNS of nonmammalian vertebrates.
In the present report, we have studied the distribution of 3p-HSD in the CNS of the frog Rana ridibunda using an antiserum raised against human placental (type I) 3@-HSD. We have also investigated the occurrence of 3@HSD activity by studying the metabolism of ASP by frog hypothalamic tissue.
Materials and Methods
Animals. Adult male frogs (Rana ridibunda) weighing 30-40 gm were obtained from a commercial source (Couttard, Saint-Hilaire de Riez, France). The animals were kept in glass tanks at 8°C under a 12 hr light-12 hr dark cycle for at least 1 week before use. They were allowed free access to running water. Animal manipulations were performed according to the recommendations of the French Ethic Committee and under the supervision of authorized investigators. To limit possible variations due to circadian rhythms (Akwa et al., 1991) , all animals were killed between 09:30 and lo:30 hr.
Antisera The antiserum against 3&HSD was raised by immunizing rabbits with purified human placental (type I) 3fi-HSD (&u-The et al, 1989) . Polvclonal rabbit anti-cow alial fibrillarv acidic orotein (GFAP) serum (Z334) was purchased from DAK0 (Glostrup, D&mark):Mono: clonal mouse anti-galactocerebroside (GalC) r-globulins (clone D12) were obtained from Boehringer (Mannheim, Germany). Fluorescein isothiocyanate-conjugated goat anti-rabbit (GARFITC) and anti-mouse (GAM/FITC) r-globulins were supplied by Nordic Immunology (Tilburg, The Netherlands). The P antiserum was a gift from Dr. C. Oliver (INSERM U297, Marseille, France). The 17-hydroxyprogesterone (170H-P) antiserum (no. 217-050 1) was produced by immunizing rabbits against 170H-P coupled to bovine serum albumin.
Chemicals and reagents. Synthetic steroids including androsterone (An), corticosterone (B), A4, DHEA, estradiol (E,), P, testosterone (T), 11 -hydroxyprogesterone (11 OH-P), 170H-P, 17-hydroxypregnenolone (1 70H-ASP), and dihydrotestosterone (ScuDHT) were supplied by Sigma (St. Louis, MO). Propylene glycol, methanol, and HEPES were purchased from Merck (Darmstadt, Germany). Trilostane (WIN 24,540) was a gift from Winthrop Laboratories (Clichy, France). Tritiated P (1,2,6,7-3H-P) and tritiated 170H-P (1,2,6,7-3H-170H-P)
were obtained from Amersham International (Buckinghamshire, UK). Tritiated ASP (7-3H-A5P) was purchased from DuPont-New England Nuclear (Les Ulis, France).
Immunofuorescence procedure. Animals were killed by cervical dislocation and perfused transcardially with 50 ml of 0.1 M phosphatebuffered saline (PBS; pH 7.3) containing 0.025% xylocaine as an anesthetic. The perfusion was carried on with 50 ml of Bouin's fixative (75 ml of saturated nitric acid. 25 ml of formaldehvde. and 5 ml of acetic acid). The brain, with the attached pituitary, wasrapidly dissected and postfixed in the same fixative solution for 24 hr. The tissues were immersed in PBS containing 15% sucrose for 12 hr and then transferred into 30% sucrose PBS for 24 hr. The brains were placed in an embedding medium (OCT Tissue-Tek, Reichert-Jung, Nussloch, Germany) and immediately frozen at -80°C. Frontal or sag&al sections (8 pm thick) were cut in a cryostat (Frigocut 2800E, Reichert-Jung, Nussloch, Germany) and mounted on glass slides coated with 0.5% gelatin and 5% chromium potassium sulfate. The tissue sections were incubated overnight at 4°C with the 3P-HSD antiserum diluted 1: 100 in PBS containing 0.3% Triton X-100 and 1% bovine serum albumin. The sections were rinsed three times in PBS for 1 hr, and then incubated for 1.5 hr at room temperature with GAR/FITC diluted 1:60. Finally, the sections were rinsed for 1 hr in PBS and mounted with PBS-glycerol (1: 1). The preparations were examined under a Leitz Orthoplan microscope or a confocal laser scanning microscope (CLSM, Leica, Heidelberg, Germany) equipped with a Diaplan optical system and an argon/krypton ion laser (excitation wavelengths: 488/568/647 nm).
Nomenclature of brain areas and nuclei was based on the stereotaxic atlas of the CNS of Rana pipiens (Wada et al., 1980) . The specificity of the immunoreaction was controlled by (1) substitution of the 3&HSD antiserum with PB. (2) reolacement of the 38-HSD antiserum by nonimmune rabbit sert&'and (3) preincubation of the 3@-HSD antiserum with human type I 3P-HSD (1O-6 M).
Consecutive sections of the preoptic nucleus were used for the identification of 3P-HSD-immunoreactive cells. One section was incubated with the 3@-HSD antiserum (diluted 1:lOO) and the adjacent section with GFAP or GalC antiserum (diluted 1:50).
Tissue extraction. Frogs were decapitated and the hypothalamus was quickly removed. Blood was collected by intracardiac puncture. The hypothalamic tissues and the blood samples were homogenized with a glass Potter homogenizer in 2.5 ml of ice-cold 10% trichloracetic acid (TCA). The samples were then submitted to three successive extractions by 2.5 ml of dichloromethane. The aqueous supematant was kept and used for determination of protein content in the extract. The organic phases were pooled and the solvent was evaporated on ice under a stream of nitrogen. The dry extracts were redissolved in 1 ml of a solution consisting of 65% water/TFA (99.9:O. 1, v/v; Sol A) and 35% methanol/ acetonitrile/TFA (90:9.98:0.02, v/v/v; Sol B) . The tissue extracts were prepurified on Sep-Pak C,, cartridges (Waters Associates, Milford, MA). Steroids were eluted with 3 ml of a solution made of 25% Sol A and 75% Sol B. The solvent was evaporated under nitrogen and the extracts were kept dry until HPLC analysis.
To determine the recovery of native steroids during the extraction procedure, samples containing either 1 ml of plasma or four hypothalamic explants were incubated for 10 min with lo8 cpm of 'H-P, homogenized, and extracted as described above. The extraction efficiency from plasma and hypothalamic tissue was 74 ? 13% and 83 + 1 l%, respectively.
Pulse-chase technique. For each experiment, the hypothalamus of four frogs was cut into two slices and preincubated for 15 min in 1 ml of Ringer's solution. The Ringer's buffer consisted of 15 mM HEPES buffer, 112 mM NaCl, 15 mM NaHCO,, 2 mM CaCl,, and 2 mM KCl, supplemented with 2 mg ofglucose/ml and 0.3 mg of BSA/ml. The incubation medium was gassed with a 95% 0,/5% CO, mixture and the DH adiusted to 7.4. The hypothalamic slices were incubated at 24°C forO.54 hr in 500 ~1 Ringer's medium containing 10m6 M tritiated ASP and 4% propylene glycol. At the end of the incubation period, the medium was removed and the tissues rinsed four times with ice-cold Ringer's buffer. The experiment was then stopped by addition of 750 ~1 of TCA. The tissue was homogenized using a glass Potter homogenizer and extracted three times by 1 ml of dichloromethane. The extracts were prepurified on Sep-Pak columns as described above and analyzed by HPLC. Control experiments were performed by replacing hypothalamic tissue by slices of frog rhombencephalon, a brain region that did not contain 3@HSD-immunoreactive cells.
High-performance liquid chromatography. Tissue extracts were analyzed by reversed-phase HPLC on a Beckmann 344 Gradient Liquid Chromatograph equipped with a Zorbax ODS/C,, column (0.46 x 25 cm) in order to characterize endogenous steroids or radioactive steroids formed by conversion of 'H-ASP. The tissue extracts, prepurified on the Sep-Pak cartridges, were injected onto the HPLC column equilibrated with a solution made of 60% Sol A and 40% Sol B (v/v) at a flow rate of 1 ml/min. The concentration of Sol B was raised to 62% over 28 min and maintained at this concentration for 12 min. Fractions were collected at 0.5 min intervals. For RIA detection of endogenous P and 170H-P or immunodetection of newly synthesized )H-170H-P in the HPLC eluent, the fractions were evaporated in a Speed Vat Concentrator (Savant, Hicksville, NY) and kept dry until assay. For measurement ofradioactive metabolites of3H-ASP, 400 ul ofeach HPLC fraction was mixed with 4 ml of liquid scintillator (Aquasafe 300 Plus, Zinner Analytic, Frankfurt, Germany) and counted in a liquid scintillation counter (LKB 12 17 Rackbeta. Rockville. MD).
In a series of experiments, 'labeled steroids'formed from )H-A5P in hypothalamic tissue were analyzed on a Nova-Pak C,, column (0.39 x 30 cm) equilibrated with 60% water/TFA (99.9:0.1, v/v; Sol A) and 40% methanol/water/TFA (90:9.98:0.02, v/v/v; Sol C) at a flow rate of 1 ml/min. Steroids were separated using a gradient of Sol C (40-80% over 70 min) including three isocratic steps at 40%, 64%, and 80% Sol C. Tritiated compounds eluted from the HPLC column were detected using a flow scintillation analyzer (Radiomatic Flo-One/Beta A-500, Packard. Meriden. CT) eauinued with a 486DX50 PC comnuter.
_ __ Synthetic steroids used as reference standards were chromatographed under the same conditions as the tissue extracts and detected by ultraviolet absorption using an ISCO-UV detector (model 1840).
Measurement of endogenous P arzd 17OH-P. For each assay, 20 frog hypothalami or 1 ml of blood was used. The amount of endogenous P and 170H-P was determined by RIA after HPLC analysis of the tissue extracts. Dried HPLC fractions were dissolved in 500 ~1 of 0.1 M borate buffer (pH 7.8) and sonicated. The final dilutions of the P and 170H-P antisera used were 1:24,000 and 1: 14,000, respectively.
Immunodetection technique. Pulse-chase HPLC fractions were reconstituted in 900 ~1 of 0.1 M borate buffer (pH 7.8). The samples were incubated overnight at 4°C with an excess of the 170H-P antiserum (diluted 1:5000). Control experiments were performed by substituting the 170H-P antiserum with nonimmune rabbit serum (diluted 1:5000) to determine nonspecific binding. Separation of bound and free radioactive steroids was performed by addition of 500 ~1 of a charcoal suspension (1% Norit charcoal and 1% dextran T70 in 0.1 M borate buffer). After centrifugation, the supematant was collected and counted for detection of antibody-bound radioactive steroids. 
Results
Immunocytochemical localization of 3p-HSD The distribution of 3P-HSD-like immunoreactivity in the frog brain is schematically presented in Figure 1 . Table 1 summarizes the localization and relative abundance of immunoreactive cell bodies and fibers.
In the telencephalon, a thin network of 3&HSD-immunoreactive fibers was observed at the basis of the lateral ventricles in the nucleus accumbens septi. Sparse fibers were also seen in the pars ventralis of the striatum, the medial forebrain bundle, the nucleus of the diagonal band of Broca, the pars lateralis of the amygdala, and the nucleus entopeduncularis.
The diencephalon contained three populations of 3P-HSDimmunoreactive cell bodies that were all located in the hypothalamus, namely, in the rostra1 part of the preoptic nucleus ( Fig. 2A) , the dorsal infundibular nucleus (Fig. 2B) , and the dorsal region of the ventral infundibular nucleus (Fig. 2C) . Examination of the hypothalamic neurons with a confocal laser scanning microscope showed that the immunoreactive material had a granular aspect and was apparently sequestered in organelles located in the cytoplasm and cytoplasmic extensions (Fig.  20) . 3P-HSD-immunoreactive fibers, which exhibited a characteristic varicose appearance, were also observed in the ventral hypothalamic nuclei (Fig. 2E) . A dense bundle of 3P-HSDpositive fibers, which was cut transversely on frontal sections, was visualized in the dorsal region of the diencephalon, that is, in the corpus geniculatus lateralis and the nucleus posterolateralis thalami (Fig. 2F) . A few positive fibers were also observed in the nucleus habenularis ventralis, the nucleus dorsolateralis anterior thalami, the nucleus posterocentralis thalami, and ventrally in the area ventrolateralis thalami and the lateral forebrain bundle.
The metencephalon, rhombencephalon, spinal cord, and pituitary were virtually devoid of immunoreactive elements. A few fibers arising from the dorsal part of the diencephalon terminated in the stratum griseum superficiale tecti of the mesencephalon.
Preincubation of the 3/I-HSD antiserum with purified human type I 3@-HSD ( 1O-6 M) resulted in complete disappearance of the immunostaining (Fig. 3A,B) . Labeling of consecutive sections with the 3P-HSD antiserum and with antisera directed against GFAP (Fig. 3C,D) or GalC (Fig. 3E,F) showed that the 3/3-HSD-immunoreactive material was not localized in GFAPor GalC-containing cells. In contrast, strong labeling of glial cells was observed with the GFAP and GalC antisera in the optic tract and amygdala, respectively (data not shown).
Measurement of endogenous P and 17OH-P The detection limit of the RIAs, corresponding to 5% displacement of the antibody-bound tracer, was 90 pg for the P RIA and 35 pg for the 170H-P RIA. The P antiserum showed 7.5% cross-reaction with ASP but did not cross-react with 170H-P. The 170H-P antiserum showed 1% cross-reaction with P, 0.85% with A5P, and 0.8% with 1 70H-A5P. The cross-reactivity of the P and 170H-P RIAs with T, SaDHT, and E, was lower than 0.1%. HPLC analysis of hypothalamic extracts combined with RIA detection of P revealed the presence of endogenous P in the frog hypothalamus (Fig. 4A) . A peak of ASP was also detected, owing to the cross-reactivity of ASP in the P RIA. A low amount of P was also detected in the HPLC fractions from blood extracts (Fig. 4B) . Similarly, the presence of endogenous 170H-P et al. l Distribution and Activity of 3&HSD i n the Hypothalamus I ItI ( / I II I -2 -1 0 +1 +2 +3 +4 +5 +6 c7 (mm) Figure 1 . Schematic frontal sections illustrating the distribution of 3p-HSD-immunoreactive cell bodies (Sr) and fibers (0) in the CNS of Rana ridibundu. The anatomical structures are designated on the right hemisections according to the nomenclature of Wada et al. (1980) . The density of the symbols is meant to be proportional to the relative density of the immunoreactive elements. The number under each drawing indicates the rostrocaudal level of the section as shown on the parasagittal schema. Abbreviations are as in Table 1. in frog hypothalamic extracts was demonstrated by combining HPLC analysis and RIA detection (Fig. 4C) . Two peaks coeluting with P and A5P were also detected by the 170H-P RIA method. 170H-P was not detectable in HPLC fractions of blood extracts (Fig. 40) . The concentrations of P and 170H-P in the hypothalamic extracts, determined from the areas under the peaks in the respective chromatograms, were 6.8 -t 1.2 and 2.1 + 0.4 ng/mg proteins, respectively (n = 4). The concentration of P in the blood extracts was 0.06 + 0.03 ng/mg proteins (n = 3).
Pulse-chase experiments A 2 hr incubation of frog hypothalamic slices with 3H-A5P yielded the formation of several radioactive metabolites. Reversedphase HPLC analysis of the tissue extracts made it possible to resolve five radioactive peaks (Fig. 54 ) one of which (peak 3) had the same retention time as 170H-P, A4, and T. Conversely, incubation of rhombencephalon slices with 3H-A5P led only to the formation of a small amount of peak 1 (Fig. 5B) . Hypothalamic slices were incubated for various durations with 'H-ASP and the radioactive metabolites were analyzed by HPLC. The kinetics of formation of peak 3 are shown in Figure 6 . A substantial amount of radioactive metabolite was detected after 30 min of incubation, and the relative quantity of radioactivity contained in peak 3 reached a maximum within 1 hr. After 4 hr of incubation, peak 3 markedly declined.
Trilostane, a specific inhibitor of 3@HSD, was used to demonstrate further the involvement of 3P-HSD activity in the formation of peak 3. Incubation of frog hypothalamic slices with 10m4 M trilostane induced a significant reduction (-34%; P < 0.05) of the conversion of 3H-ASP into peak 3 metabolites (Fig.  7) .
Extracts of hypothalamus explants incubated for 2 hr with 3H-A5P were analyzed using a different HPLC system equipped with a flow scintillation analyzer that permitted separation of 170H-P, T, and A4. In these conditions, radioactive metabolites coeluting with SolDHT, 170H-ASP, 170H-P, and P were resolved (Fig. 8) .
Immunodetection of radiolabeled 17OH-P Hypothalamic slices were incubated with 1O-6 M 3H-ASP for 2 hr and the tissue extract analyzed by HPLC (Fig. 9A) . Incubation of all HPLC fractions with the 170H-P antiserum revealed the existence of two peaks that apparently contained 170H-P-like immunoreactivity (Fig. 9B) . These peaks exhibited the same retention time as 170H-P and ASP, respectively. Incubation of the HPLC fractions with a nonimmune rabbit serum showed that the second peak, coeluting with ASP, was attributable to the large excess of tracer that could not be totally adsorbed by the charcoal suspension during separation (Fig. 9C ).
Discussion
Biochemical studies have previously demonstrated the occurrence of 3&HSD activity in primary cultures of glial cells and/ or neurons from newborn rats (Jung-Testas et al., 1989) and mouse embryos (Bauer and Bauer, 1989 ). The present work provides the first immunocytochemical description of the distribution of 3&HSD in the CNS of vertebrates. This report also demonstrates that hypothalamic tissue from adult frogs displays 3B-HSD activity in vivo and in vitro. We have taken advantage of the availability of specific 3@-HSD antibodies to determine the anatomical distribution and cellular localization of 3&HSD-like immunoreactivity in the CNS of the frog. The 3@-HSD antiserum used in this study has already been successfully applied to the immunocytochemical localization of 3&HSD in "conventional" steroid-producing organs of mammals, such as the adrenal, testis, ovary, and placenta (Dupont et al., . The preadsorption experiments described herein confirmed the specificity of the immunostaining. However, although the antibodies were raised against type I human placental 3&HSD (Luu-The et al., 1989) , they also recognize other 3P-HSD isotypes, in particular, type II 3P-HSD (DuPont et al., 199Oa<) , which is the predominant form expressed in the adrenal and gonads (Lachance et al., 1991) . Therefore, the immunoreactive material detected in the frog brain may correspond to any variant(s) of the 3/3-HSD family. The cells exhibiting 3/3-HSD-like immunoreactivity were exclusively found in three discrete hypothalamic nuclei. The most rostra1 group of positive cell bodies was located in the preoptic nucleus, a formation that is homologous to the supraoptic and paraventricular nuclei of the brain of mammals (Wada et al., 1980) . Two other populations of immunoreactive cells were found more caudally in the dorsal and ventral infundibular nuclei. Anatomically and functionally, the ventral infundibular nucleus of amphibians is homologous to the arcuate nucleus of mammals (Wada et al., 1980) . Specifically, in both amphibians and mammals, these nuclei contain several populations of neurons that synthesize a wide range of regulatory neuropeptides (Jacobowitz, 1988; Andersen et al., 1992) . A dense bundle of 3@-HSD-immunoreactive fibers was detected in the lateral tegmentum of the frog, particularly in the lateral thalamic neuropil, the corpus geniculatus lateralis, and the nucleus posterolateralis thalami. In amphibians as in mammals, all these structures that receive tectal afferences are thought to participate in the formation of a tectotegmentospinal pathway (Masino and Grobstein, 1990) . A discrete network of 3@-HSD-immunoreactive fibers was also visualized in the nucleus accumbens septi, a formation that is homologous to the septum of mammals (Northcutt and I&liter, 1980) . Identification of astrocytes with antisera against GFAP (Nagle, 1988) and oligodendrocytes with antisera against GalC (Raff et al., 1978) revealed that, in the frog brain, the 3P-HSD-immunoreactive material is not expressed in glial cells. In addition, the 3P-HSD-positive fibers visualized in the diencephalon and telencephalon exhibited the typical varicose aspect of beaded nerve fibers, whereas neuroglial and ependymal cells display only thick and linear processes (Oksche and Ueck, 1976; Malagon et al., 1992) . These observations indicate that in the frog brain, the 3fi-HSD-immunoreactive material is exclusively expressed in neurons. In agreement with this finding, it has been recently demonstrated that in rat, mRNAs encoding for type I 3/3-HSD are synthesized only in neurons (DuPont et al., 1994) . However, since 3/I-HSD enzymatic activity has been detected in cultures of glial cells from fetus (Kabbadj et al., 1993) and newborn rat brains (Jung-Testas et al., 1989 ), it appears that other isoforms of 3@-HSD may also be expressed in non-neuronal cells.
To our knowledge, the distribution of 3/3-HSD-immunoreactive neurons has never been determined before in the CNS of any species. Therefore, the immunocytochemical mapping of 3/3-HSD described herein can only be compared to the regional distribution of 3/?-HSD activity previously reported in the rat brain. In agreement with the present findings, 3@HSD activity has been detected in rat septum (which is homologous to the frog nucleus accumbens septi) and hypothalamus (Weidenfeld et al., 1980; Robe1 et al., 1986) . The absence of significant 3P-HSD activity in the cerebellum and in the cerebral cortex of the rat (Weidenfeld et al., 1980; Robe1 et al., 1986 ) is also consistent with the present data. In contrast, a high level of 3P-HSD activity has been reported in the rat amygdala (Weidenfeld et al., 1980) while only a few 3&HSD-positive fibers were visualized in the frog amygdala. Similarly, 3/I-HSD activity has been detected in the rat hippocampus, whereas the frog pallium (which is homologous of the hippocampal formation of mammals) was virtually devoid of 3P-HSD-immunoreactive elements. These differences may be ascribed to the presence of isoforms of 3P-HSD that were not detected by the antiserum.
Presence of endogenous A4-3-ketosteroids in the frog hypothalamus HPLC analysis of tissue extracts combined with RIA detection revealed the presence of substantial amounts of P-and 170H-P-immunoreactive compounds in the frog hypothalamus. In fact, the concentration of P in the frog hypothalamus was only four times lower than that detected in the adrenal gland, which, in the male frog, is the main source of plasma P (Leboulenger et al., 198 1) . Previous studies have demonstrated that, in male rats, the concentrations of P in brain and plasma are in the same range, that is, 2.5 ng/gm tissue (Corptchot et al., 1993) . Conversely, in male frogs, the concentration of P was 100 times higher in hypothalamic extracts than in plasma, while 170H-P was not detectable in frog blood. Therefore, our results strongly suggest that synthesis of P and 170H-P occurs in the frog hypothalamus. However, these data do not exclude the possibility that a proportion of brain steroids could originate from selective uptake of P from the plasma.
Conversion of ASP into P and 17OH-P by hypothalamic explants To demonstrate that synthesis of P and 170H-P actually occurred in the frog hypothalamus, pulse-chase experiments were conducted to investigate the conversion of tritiated ASP into radioactive metabolites. The data described herein showed that hypothalamic slices exhibit the capability of synthesizing various steroids from ASP. In particular, the results provide strong evidence for 3P-HSD bioactivity in frog hypothalamic tissue:
(1) part of the newly synthesized steroids exhibited the same retention time as P and 170H-P in different chromatographic systems; (2) the conversion of 3H-ASP into these metabolites Elution time (min) Figure 5 . HPLC analysis of steroids extracted from (A) hypothalamic slices or (B) rhombencephalon slices after a 2 hr incubation with 'Hpregnenolone using a water-TFA/methanol-acetonitrile gradient. The ordinate indicates the radioactivity measured in the HPLC fractions (0.5 ml each). The dashed line represents the gradient of secondary solvent (% Sol B). The peaks of radioactive steroids are designated by consecutive numbers (I-5). The arrows indicate the elution position of standard steroids: B, corticosterone; 1 I OH-P, 11 -hydroxyprogesterone; I7OH-P, 17-hydroxyprogesterone; A4, androstenedione; T, testosterone; 1 7OH-ASP, 17-hydroxypregnenolone;
SaDHT, dihydrotestosterone (androstanolone); P, progesterone; DHEA, dehydroepiandrosterone; ASP, pregnenolone.
was significantly reduced when the pulse-chase experiments were conducted in the presence of trilostane, a specific inhibitor of 3&HSD (Komanicky et al., 1978) ; and (3) the newly synthesized steroids comigrating with 170H-P were selectively immunodetected using 170H-P antibodies. A good correlation was found between the distribution of 3&HSD-immunoreactive neurons and the location of 3&HSD bioactivity in the frog brain. In particular, the rhombencephalon that was totally devoid of immunoreactive elements did not exhibit any capability of converting ASP into 170H-P, A4, or T, as shown in Figure SB . This correlation strongly suggests that the 3&HSD-immunoreactive material detected in frog hypothalamic neurons corresponds to Incubation time (Hours) l Figure 6 . Kinetics of the conversion of 'H-pregnenolone into radioactive peak 3 by hypothalamic slices. The values were obtained from experiments similar to that presented in Figure 5 . The ordinate represents the relative amount of peak 3 compared to the total amount of radiolabeled compounds resolved by HPLC analysis ( 100 x ).
Control Trilostane was calculated as the relative amount of peak 3 compared to the total amount of radiolabeled compounds resolved by HPLC analysis (100 x ). Each value is the mean (? SEM) of three independent experiments. Ir, P < 0.05. Elution time (min) Figure 8 . Analysis of steroids extracted from hypothalamic slices after a 2 hr incubation with 'H-pregnenolone using a water-TFA/methanol gradient and an HPLC system equipped with a flow scintillation analyzer. The ordinate indicates the radioactivity measured in the HPLC eluent. The dashed line represents the gradient of secondary solvent (% Sol C). The arrows indicate the elution position of standard steroids: 1 70H-ASP, 17-hydroxypregnenolone; 5aDHT, dihydrotestosterone (androstanolone); An, androsterone; DHEA, dehydroepiandrosterone; B, corticosterone; 11 OH-P, 11 -hydroxyprogesterone; A', androstenedione; E,, estradiol; T, testosterone; 17OH-P, 17-hydroxyprogesterone; P, progesterone; ASP, pregnenolone.
an active form of the enzyme. Since conversion of 3H-A5P into 3H-170H-A5P may occur (as shown in Fig. 7 ) it appears that 170H-P may be synthesized through two alternative biosynthetic pathways: A5P + P -+ 170H-P and ASP * 170H-A5P -170H-P. Interestingly, kinetics experiments showed that the absolute amount of 3H-170H-P synthesized from 3H-A5P reached a maximum within 2 hr and rapidly decreased during the next 2 hr. This observation indicates that 170H-P is not only an endproduct steroid in the brain, but likely serves as a precursor for other neurosteroids. Biosynthesis of A4, a metabolite of 170H-P, has been demonstrated in rat hypothalamic explants incubated with 3H-DHEA (Robe1 et al., 1986) . However, the data shown in Figure 7 do not provide evidence for the formation of A4 in the frog brain. Concurrently, 170H-P has never been identified in the CNS of mammals and all attempts to demonstrate P450,,,-like immunoreactivity have been unsuccessful (for review, see Akwa et a., 1991 ). It appears, therefore, that substantial differences in the biosynthetic pathways of steroids occur in the brain of various classes of vertebrates. Further experiments are in progress to characterize the different steroids synthesized in the CNS of the frog.
Physiological implications
Neurosteroids have been shown to have a number of biochemical and behavioral effects (Beaulieu and Robel, 1990) . In particular, various neuroactive steroids modulate GABAergic neurotransmission (Akwa et al., 1991) . The presence of 3fl-HSDimmunoreactive neurons in the preoptic and infundibular nuclei of the frog brain, which contain a dense network of GABAergic fibers and nerve terminals (Franzoni and Morino, 1989) , suggests that neurosteroids may act presynaptically on GABAergic neurons by controlling the activity of glutamate decarboxylase, as previously shown in the rat brain (Wallis and Luttge, 1980) . Alternatively, recent studies revealed that the preoptic nucleus and the dorsal and ventral infundibular nuclei of the frog brain contain GABA,-benzodiazepine receptors (Tavolaro et al., 1993) . Since several neuroactive steroids act as allosteric modulators of the GABA, receptor complex (Majewska, 1992) , the present data suggest that steroids synthesized within the frog hypothalamus may regulate GABAergic neurotransmission postsynaptically by interacting with the GABA,-benzodiazepine receptor.
In the amphibian brain, the neuronal systems involved in the control of the activity of pituitary cells are generally located in the preoptic nucleus and/or in the dorsal and ventral infundibular nuclei (Andersen et al., 1992) . Specifically, neurons producing thyrotropin-releasing hormone (Lamaci et al., 1989) , somatostatin (Laquerribre et al., 1989) , corticotropin-releasing hormone growth hormone-releasing hormone (Marivoet et al., 1988) , neuropeptide Y (Danger et al., 1985) , gonadotropin-releasing hormone (Conlon et al., 1993) and pituitary adenylate cyclase-activating polypeptide (Yon et al., 1992) are located in one or several of these hypothalamic nuclei. The occurrence of 3/?-HSD-immunoreactive neurons in these hypothalamic hypophysiotropic centers suggests that neurosteroids may exert neuroendocrine functions by modulating The presence of 3P-HSD-like immunoreactivity in long bead-
The Journal of Neuroscience, December 1994, 14(12) 7317 ed nerve fibers indicates that neurosteroids can be synthesized not only in cell bodies but also in axons and thus released at a distance of 3P-HSD-immunoreactive perikarya. In particular, the dense network of 3@-HSD-immunoreactive fibers visualized in the lateral neuropil of the thalamus appeared to connect the rostra1 part of the hypothalamus to the tectum. Inasmuch as these tectotegmental connections play a major role in visually elicited orienting movements (Masino and Grobstein, 1990 ), 3@-HSD-containing neurons may be involved in the processing of visual information leading to orienting behavior. In summary, the present study provides the first description of the distribution of 3P-HSD-like immunoreactivity in the brain. The results demonstrate the existence of three discrete populations of 3&HSD-immunoreactive neurons in hypothalamic hypophysiotropic centers. Our study also shows that hypothalamic explants are capable of converting ASP into P and 170H-P. Taken together, these data indicate that, in the frog brain, steroids produced in neurons (and not in glial cells) may be involved in the regulation of neuroendocrine functions.
